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September 2011916 AbstractsResults: Of 632 patients, 586 (522 group 1, 64 group 2) had data
available for analysis with a mean follow-up of 26months. During EVAR, 60
patients (94%) in group 2 underwent coil embolization and coverage of the
internal iliac artery. In group 2 patients, the 5-year endoleak-free survival was
significantly lower (57%  10% vs 72  5%; P  .018), incidence of distal
iliac artery attachment site (type Ib) endoleak was significantly higher (0.7%
vs 7.8%, P  .001), and reintervention-free survival was significantly lower
(68%  11% vs 77  4%, P  .027). Anatomy in 42 patients (66%) was
deemed suitable for use of iliac branched grafts, and presence of a hypogas-
tric artery aneurysm was the most frequent reason restricting iliac branched
grafts candidacy.
Conclusions: Patients with aneurysms involving the iliac bifurcation
usually require internal iliac artery sacrifice during EVAR and have worse
long-term outcomes, with significantly higher rates of endoleak and reinter-
vention. The anatomy in 50% of these patients is suitable for internal iliac
preservation with an iliac branched graft, which could improve long-term
outcomes after EVAR in patients with iliac involvement.
Duplex Ultrasound Imaging to Detect Endovascular Aneurysm Repair
Limb Stenosis or Kinking After Midterm Follow-up
Aaron S. Blom, DO, MBA, Douglas Troutman, DO, Brian Beeman, MD,
Mark Yarchoan, BA, Matthew J. Dougherty, MD, Keith D. Calligaro, MD,
Pennsylvania Hospital, Philadelphia, Pa
Objective(s): We attempted to determine the utility of duplex ultra-
sound (DU) imaging in predicting endovascular aneurysm repair (EVAR)
limb stenosis or kinking.
Methods: Between 1998 and 2010, 248 patients underwent EVAR
and postoperative DU surveillance of 496 limbs in our accredited noninva-
sive vascular laboratory by one of three experienced technologists. Routine
DU surveillance was performed at 1 week, 6 months, and annually after
grafts inserted during EVAR. Peak systolic velocities (PSVs) were measured
in the mid-portion and distal anastomoses of both limbs of the graft, and
adjacent PSV ratios were calculated.
Results:None of 479 limbs with a PSV300 cm/s occluded during a
mean midterm follow-up of 22.3 months (range, 1-123 months). Of 17
limbs with a PSV 300 cm/s, 12 occluded (n  7; 0/479 vs 7/17, p 
0.01) or underwent prophylactic intervention (n  5; mean adjacent PSV
ratio  7.3), and 5 limbs remained patent without intervention (mean PSV
ratio  2.0; sensitivity  100%; specificity  95%).
Conclusions: This is the largest reported series of DU surveillance for
failing EVAR devices and suggests that limbs with PSVs 300 cm/s can be
safely monitored. However, limbs with more elevated PSVs may benefit
from prophylactic intervention ormore frequent surveillance to prevent limb
occlusion.
Chronic Kidney Disease Class Predicts Mortality After Abdominal
Aortic Aneurysm Repair in Propensity-Matched Cohorts from the
Medicare Population
Nathan J. Aranson, MD, Virendra I. Patel, MD, Emel Ergul, MS, Glenn M.
LaMuraglia, MD, Christopher J. Kwolek, MD, Richard P. Cambria, MD,
Mark F. Conrad, MD, Massachusetts General Hospital, Boston, Mass
Objective(s):Chronic renal insufficiency (CKD) is a predictor of death
after abdominal aortic aneurysm (AAA) repair. However, few studies are
adequately powered to stratify risk by CKD severity. The goal of this study
was to assess the effect of CKD severity on survival after AAA repair.
Methods: All patients who underwent open or endovascular AAA
repair from 2006 to 2007 were retrospectively identified in the Medicare
database and stratified by CKD stage into 3 groups: normal (CKD 0-1),
moderate (CKD 2-4), and severe (CKD 5-6). Propensity matching (30:1) of
known risk factors was performed. The primary outcome was death; second-
ary outcomes included hospital length of stay (LOS) and cost.
Results: We identified 47,715 patients (96.7% normal, 1.88% moder-
ate, 1.65% severe). After propensity matching, there was no difference in
comorbidities between cohorts. The 30-day mortality was significantly
higher in the moderate (5.7%) vs normal (2.5%, P  0.0001) and severe
(9.9%) vs normal (1.8%; P 0.0001) groups. The 3-year survival favored the
normal cohort (80%) vs moderate (64%; P  0.0001) and 81% vs severe
(44%; P  0.0001). Hospital LOS increased with CKD severity (4.4 days
normal vs 6.5 moderate, P  .0001; 4.7 normal vs 9.1 days severe, P 
.0001) as did cost ($77,275 normal vs $97,410 moderate, P  .0001;
$73,273 normal vs $113,863 severe, P  .0001).
Conclusions: CKD severity is an important predictor of perioperative
mortality and long-term survival after AAA repair in propensity matched
cohorts. The fivefold increase in 30-day mortality and mere 44% 3-year
survival suggest that elective AAA repair is contraindicated in most patients
with severe CKD.mproved Long-term Results Using Onyx Glue for the Treatment of
ersistent Type II Endoleak After Endovascular Aneurysm Repair
hristopher J. Abularrage, MD, Virendra I. Patel, MD, Mark F. Conrad,
D, Richard P. Cambria, MD, Christopher J. Kwolek, MD, Johns Hopkins
ospital, Baltimore, Md
Objective(s): Persistent type II (PTII) endoleaks after EVAR are the
ost common indication for reintervention; however, these reinterventions
re associated with inferior results. This study evaluated outcomes of rein-
ervention for PTII endoleak during an 8-year period.
Methods: From 1999 to 2007, PTII endoleak developed in 136 of
32 patients. Patients with other types of endoleak were excluded from
nalysis. Primary end points included PTII resolution (reinterventional
uccess), change in aneurysm sac size, and survival. End points were evalu-
ted using 2 and Kaplan-Meier analyses.
Results: Forty-nine patients underwent 65 endovascular reinterven-
ions for PTII and an expanding aneurysm sac with a median follow-up of
3.7 months (Table). Reintervention success rate was 40% (26 of 65). Onyx
lue embolization was associated with a greater success rate (76% vs 31%,
 .0005) and inferior mesenteric artery coil embolization had a lower
uccess rate (20% vs 52%, P  .03). The mean change in aneurysm sac
iameter from preintervention to the maximum follow-up was decreased
nly in the Onyx glue embolization group (–2.25  1.39 vs 2.98  0.75
m, P  .0008). Survival at 5 years was 72.3%  0.08% and was not
redicted by any of the reinterventional techniques.
Conclusions:Reintervention for PTII is associated with success in 40%
f cases. Onyx glue embolization led to increased success rates and decrease
n the aneurysm sac diameter, and therefore, should be considered as
rst-line therapy for treating PTII endoleak.
able. Endovascular reinterventions
ariable No.
Long-term success
No. (%) P
ll endovascular reinterventions 65 26 (40) .006
nyx glue 17 13 (76)
on-Onyx glue 10 2 (20)
oil embolization
Lumbar 7 3 (43)
Sac 11 4 (36)
Inferior mesenteric artery 20 4 (20)
idterm Outcome of Endovascular Popliteal Artery Aneurysm Repair
sing the Viabahn Endoprosthesis
aran Garg, Caron B. Rockman, MD, Billy J. Kim,MD, Glenn R. Jacobow-
tz, MD, Thomas S. Maldonado, MD, Patrick J. Lamparello, MD, Mark A.
delman, MD, Frank J. Veith, MD, Neal S. Cayne, MD, New York
niversity Langone Medical Center, New York, NY
Objective(s):This study reviews a single-center experience of endovas-
ular popliteal aneurysm repair with Viabahn® endoprosthesis (W.L. Gore
Associates, Inc, Flagstaff, Ariz).
Methods: A retrospective review was performed to identify all endo-
ascular popliteal artery aneurysm (PAA) repairs performed between Sep-
ember 2004 and January 2011. A total of 21 patients (91% male; mean age,
4 9 years) with PAAs (mean size 2.89 1.0 cm, 38% symptomatic) in 26
imbs were identified. All underwent endovascular repair with a Viabahn®
overed stent graft. Patient and operative characteristics are listed in the
ccompanying Table. All patients were maintained on antiplatelet therapy
ostoperatively with clopidogrel and/or aspirin.
able. Study characteristics
ariables Mean  SD, or No. (%)
atient considerations
Age, years 74  9
Male sex 19/21 (90.5)
Bilateral popliteal aneurysms 10/21 (48)
History of AAA 11/21 (52)
AAA diameter (median), cm 2.89  1.0
Percentage asymptomatic 16/26 (62)
perative considerations
Locoregional anesthesia 17/26 (65)
Technical success 25/26 (96)
